HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada · Delayed Price · Currency is CAD
3.790
+0.090 (2.43%)
Aug 28, 2026, 3:59 PM EST

HLS Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.57-12.43-19.66-27.53-23.6-13.12
Depreciation & Amortization
22.0421.8222.7231.9434.430.26
Loss (Gain) From Sale of Assets
---3.38---
Asset Writedown & Restructuring Costs
---3.893.05-
Loss (Gain) From Sale of Investments
--0.532.89-2.33-1.97
Stock-Based Compensation
1.231.911.62-0.542.922.35
Other Operating Activities
-0.921.15.040.10.951.92
Change in Accounts Receivable
0.22-0.072.360.63-0.071.04
Change in Inventory
0.431.28-0.19-0.66-0.621.77
Change in Accounts Payable
0.980.84-4.31.993.24-3.65
Change in Income Taxes
-0.060.33-0.110.39-0.29-0.45
Change in Other Net Operating Assets
2.912.353.392.69-0.71-1.74
Operating Cash Flow
18.2517.13815.7916.9416.43
Operating Cash Flow Growth
41.99%114.05%-49.31%-6.81%3.12%75.82%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.1-0.21-0.02-0.04-0.05-0.05
Cash Acquisitions
---1.5---
Sale (Purchase) of Intangibles
-0.94-1.513.25-0.15-10.1-4.46
Investing Cash Flow
-1.04-1.711.74-0.19-10.15-4.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-57.24--10-
Long-Term Debt Repaid
--75.61-21.57-9.46-10.44-11.14
Net Debt Issued (Repaid)
-13.11-18.37-21.57-9.46-0.44-11.14
Issuance of Common Stock
0--0.130.184.91
Repurchase of Common Stock
-0.81-1.8-0.6-1.55-1-0.05
Common Dividends Paid
----2.4-4.96-5.12
Other Financing Activities
-1.39-1.39-1.19-1.36-0.64-
Financing Cash Flow
-15.3-21.56-23.36-14.64-6.86-11.4

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.340.4-0.870.27-0.390.05
Net Cash Flow
1.58-5.73-4.51.23-0.460.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18.1516.937.9915.7516.916.38
Free Cash Flow Growth
42.58%111.88%-49.28%-6.80%3.14%76.00%
Free Cash Flow Margin
32.28%30.50%14.11%24.97%27.49%27.30%
Free Cash Flow Per Share
0.580.540.250.490.520.51
Levered Free Cash Flow
20.5119.6426.3924.7115.6312.13
Unlevered Free Cash Flow
23.5724.0832.6930.1820.216.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----6.516.17
Cash Income Tax Paid
0.570.340.380.030.030.62
Change in Working Capital
4.474.731.145.041.55-3.02